Infant brain tumors

Brain and Spinal Tumors of Childhood

Volumn , Issue , 2004, Pages 359-369

  Michalski, Antony ^a   Garré, Maria Luisa ^b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057938319     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (83)

1. Duffner PK. Brain tumours in infants and very young children. In: Cohen ME, Duffner PK (eds). Brain Tumours in Children: Principles ofDiagnosis and Treatment, 2nd edn. New York: Raven Press, 1994.
2. Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med1993; 328:1725-31.
3. Malcon AS, Lynn A, Gloecker R. Childhood cancer: Incidence, survival and mortality. In: Pizzo PA, Popack DG (eds). Principles and Practice of Pediatric Oncology, 4th edn. Philadelphia: Lippincott William and Wilkins, 2002.
4. Ries L, Smith M, Gurney JG, et al. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. NHI publication no. 99-4649. Bethesda, MD: National Cancer Institute, SEER program, 1999.
5. Parkin DM, Kramarova E, Draper GJ, et al. International Incidence of Childhood Cancer, vol. II. Lyon: Iarc Scientific Publications, 1998.
6. Haddad SF, Menezes AH, Bell WE, Godersky JC, Afifi AK, Bale JF. Brain tumours occurring before 1 year of age: A retrospective review of 22 cases in a 11-year period (1977-1987). Neurosurgery 1991; 29:8-13.
7. Choen BH, Packer RJ, Siegel KR, et al. Brain tumours in children under 2 years: Treatment, survival and long term prognosis. Pediatr Neurosurg 1993; 19:171-9.
8. Kleihues P, Cavenee WK. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Nervous System. Lyon: Iarc Press, 2000.
9. Plon SE, Malkin D. Childhood cancer and heredity. In: Pizzo PA, Popack DG (eds). Principles and Practice of Pediatric Oncology, 4th edn. Philadelphia: Lippincott William and Wilkins, 2002.
10. Miyaki M, Nishio J, Konishi M, et al. Drastic genetic instability of tumours and normal tissues in Turcot syndrome. Oncogene1997; 15:2877-81
11. Pietsch T, Waha A, Koch A, et al. Medulloblastoma of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res 1997; 57:2085-8.
12. Zurawell RH, Allen C, Chiappa S, et al. Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma genes. Genes Chromosomes Cancer 2000; 27:44-51.
13. Huang H, Betania M, Mahler-Araujo M, et al. APC mutations in sporadic medulloblastoma. Am J Pathol 2000; 156:433-7.
14. Yuasa H, Tokito S, Tokunaga M. Primary carcinoma of the choroid plexus in Li-Fraumeni syndrome: Case report. Neurosurgery 1993; 32:131-3.
15. Malkin D, Chilton-MacNeil S, Meister LA, Sexsmith E, Diller L, Garcea RL. Tissue specific expression of SV40 in tumours associated with the Li-Fraumeni syndrome. Oncogene 2001; 20:4441-9.
16. Giangaspero F, Perilongo G, Fondelli MP, et al. Medulloblastoma with extensive nodularity: A variant with favourable prognosis. J Neurosurgery 1999; 91:971-7.
17. Tenreiro-Picon OR, Kamath SV, Knorr JR, Ragland RL, Smith TW, Lau KY. Desmoplastic infantile ganglioglioma: Ct and MRI features. Pediatr Radiol 1995; 25:540-3.
18. Vanderberg SR, May EE, Rubistein LJ, et al. Desmoplastic supratentorial neuroepithelial tumours of infancy with divergent differentiation potential (desmoplastic infantile gangliogliomas). Report of 11 cases of a distinctive embryonal tumour with favourable prognosis. J Neurosurgery 1987; 66:58-71.
19. Vanderberg SR. Desmoplastic infantile ganglioglioma: A clinicopathological review of sixteen cases. Brain Tumour Pathol 1991; 8:25-31.
20. Vandenberg SR. Desmoplastic infantile ganglioglioma and desmoplastic cerebral astrocytoma of infancy. Brain Pathol1993; 3:275-81.
21. Gobel U, Haas RJ, Calaminus G, et al. Treatment of germ cell tumours in children: Results of European Trials for testicular and non-testicular primary sites. Crit Rev Oncol Hematol 1990; 10:89-98.
22. Flamant F. Baranzelli MC, Kalifa C, Lemerle J. Treatment of malignant germ cell tumours in children: Experience of the Institute Gustave Roussy and the French Society of Pediatric Oncology. Crit Rev Oncol Hematol 1990; 10:99-110.
23. Ferreira J, Eviatar L, Schneider S, Grossman R. Prenatal diagnosis of intracranial teratoma. Prolonged survival after resection of a malignant teratoma diagnosed prenatally by ultrasound: A case report and review of literature. Pediatr Neurosurg 1993; 19:84-8.
24. Garrè ML, El-Hossainy MO, Fondelli P, et al. Is chemotherapy effective therapy for intracranial immature teratoma. Cancer1996; 77:977-82.
25. Berger C, Thiesse P, Lellouch-Tubiana A, Kalifa C, Pierre-Kahn A, Bouffet E. Choroid plexus ca in childhood: Clinical features and prognostic factors. Neurosurgery 1998; 42:470-5.
26. Duffner PK, Kun LE, Burger PC, et al. Postoperative chemotherapy and delayed radiation in infants and very young children with choroid plexus carcinomas. The Paediatric Oncology Group. Pediatr Neurosurg 1995; 22:189-96.
27. Pencalet P, Sainte-Rose C, Lellouch-Tubiana A, et al. Papillomas and carcinomas of the choroid plexus in children. J Neurosurg 1998; 88:521-8.
28. Mc Evoy AW, Harding BN, Phipps KP, et al. Management of choroid plexus tumours in children: 20 years experience at a single neurosurgical center. Pediatr Neurosurg 2000; 32:192-9.
29. Chow E, Reardon DA, Shah AB, et al. Pediatric choroid plexus neoplasm. Int J Radiat Oncol Biol Phys 1999; 44:249-54.
30. Diengdoh JV, Show M. Oncocytic variant of choroid plexus papilloma. Evolution from benign to malignant oncocytoma. Cancer 1993; 71:855-8.
31. Garrè ML, Brisigotti M, Capra V, et al. Frequency and biological behaviour of choroid plexus (CP) tumours in children. Neuro-Oncol 2000; 2 (suppl. 1).
32. Sanford RA, Horowitz ME, Kun LE, Jenkins JJ, Simmons JCH, Kovnar EH. Preoperative chemotherapy to facilitate the total resection of paediatric brain tumours. In: Marlin AE (ed.). Concepts in Pediatric Neurosurgery, vol. 9. Basel: Karger, 1989, pp. 139-52.
33. Tihan T, Burger PC. A variant of pylocitic astrocytoma: A possible distinct clinicopathological entity with a less favourable outcome. J Neuropathol Exp Neurol 1998; 57:495-500.
34. Cottingham SL, Bosel CP, Yates AJ. Pylocitic astrocytoma in infants: A distinctive histological pattern. J Neuropathol Exp Neurol 1996; 55:654.
35. Becker LE, Cruz-Sanchez FF. Ependymoblastoma. In: Kleihues P, Cavenee WK. Pathology and Genetics of Tumours of the Nervous System. Lyon: Iarc Press, 2000.
36. Mork SJ, Rubinstein LJ. Ependymoblastoma. A reappraisal of a rare embryonal tumour. Cancer 1985; 55:1536-42.
37. Dorsay TA, Rovira MJ, Ho VB, Kelley J. Ependymoblastoma: Mr presentation. A case report and review of literature. Pediatr Radiol 1995; 25:433-5.
38. Wada C, Kurata A, Hirose R, et al. Primary leptomeningeal ependymoblastoma. Case report. J Neurosurg 1986; 64:968-73.
39. Marec-Berard P, Jouvet A, Thiesse P, Kalifa C, Doz F, Frappaz D. Supratentorial embryonal tumours in children under 5 years an SFOP study of treatment with postoperative chemotherapy alone. Med Pediatr Oncol 2002; 38:83-90.
40. Bonnin JM, Rubistein LJ, Palmer NF. The association of embryonal tumours originating in the kidney and in the brain. A report of seven cases. Cancer 1984; 54:2137-46.
41. Parham DM, Weeks DA, Becwith JB. The clinico-pathological spectrum of putative extrarenal rhabdoid tumours. An analysis of 42 cases studied with immunohistochemistry or electron microscopy. Am J Surg Pathol 1994; 18:1010-20.
42. Rorke LB, Packer RJ, Biegel JA. Central nervous system atypical teratoid/rhabdoid tumours of infancy and childhood. J Neuro-Oncol 1995; 24:21-8.
43. Rorke LB, Packer RJ, Biegel JA. Central nervous system atypical teratoid/rhabdoid tumours of infancy and childhood definition of an entity. J Neurosurg 1996; 85:56-65.
44. Burger PC, Yu IT, Friedman HS, et al. Atypical teratoid/rhabdoid tumour of the central nervous system. A highly malignant tumour of infancy and childhood frequently mistaken for medulloblastoma. A Paediatric Oncology Group Study. Am J Surg Pathol 1998; 22:1083-92.
45. Giannini C, Garrè ML, Oka H. Atypical teratoid/rhabdoid tumour of the central nervous system: An aggressive pediatric brain tumour. Path Case Rev 1998; 3:301 -8.
46. Biegel JA. Cytogenetics and molecular genetics of childhood brain tumours. Neurooncol 1999; 1:139-51.
47. Biegel JA, Zhou JY, Rorke L, Stenstrom C, Wainwright, W, Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999; 59:74-9.
48. Taylor MD, Gokgoz N, Andrulis IL, Mainprize TG, Drake JM, Rutka JT. Familial posterior fossa brain tumours of infancy secondary to germiline mutation of the hSNF5 gene. Am J Hum Genet 2000; 66:1403-6.
49. Tortori-Donati P, Fondelli MP, et al. Atypical teratoid/rhabdoid tumours of the central nervous system in infancy - neuroradiological findings. Int J Neuroradiol1997; 3:327-38.
50. Olson TA, Bayar E, Kosnik E, et al. Successful treatment of disseminated central nervous system malignant rhabdoid tumour. J Pediatr Hematol Oncol 1995; 17:71 -5.
51. Hildel JM, Watterson J, Longee DC, et al. Central nervous system atypical teratoid tumour/rhabdoid tumour: Response to intensive therapy and review of literature. J Neuro-Oncol 1998; 40:265-75.
52. Garrè ML, Giannini C, Brisigotti M, et al. Central nervous system (CNS) atypical teratoid/rhabdoid tumour (AT/RT): Survival and prognostic factors in 15 cases included in the Italian Cooperative Study for children <3yrs of age. Neuro-Oncol 2000; 2 (suppl. 1).
53. Geyer JR, Finlay JL, Boyett JM, et al. Survival of infants with malignant astrocytomas. A report from the Children's Cancer Group. Cancer 1995; 75:1045-50.
54. Duffner PK, Horowitz ME, Krischer JP, et al. The treatment of malignant brain tumours in infants and very young children: An update of the Pediatric Oncology Group experience. Neuro-Oncol 1999; 1:152-61.
55. Kunwar S, Mohapatra G, Bollen A, Lamborn KR, Prados M, Feuerstein BG. Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival. Cancer Res 2001; 61:7683-8.
56. Pollack IF, Finkelstein SD, Woods J, et al. Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med 2002; 7; 346:420-7.
57. Pollack IF, Finkelstein SD, Burnham J, et al. Age and TP53 mutation frequency in childhood malignant gliomas: Results in a multi-institutional cohort. Cancer Res 2001; 61:7404-7.
58. Cruz-Sanchez FF, Rossi ML, Hughes JT, Moss TH. Differentiation in embryonal neuroepithelial tumours of the central nervous system. Cancer 1991; 67:965-76.
59. Tait DM, Thornton-Jones H, Bloom HJG, Lemerle H, Morris-Jones P. Adjuvant chemotherapy for medulloblastoma: The first multi-center control trial of the International Society of Pediatric Oncology (SIOPI). Eur J Cancer 1990; 26:464-9.
60. Geyer R, Levy M, Berger MS, Milstein J, Griffin B, Bleyer WA. Infants with medulloblastoma: A single institution review of survival. Neurosurgery 1991; 29:707-11.
61. Jannoun L, Bloom HJG. Long term psychological effects in children treated for intracranial tumours. Int J Radiat Oncol Biol Phys 1989; 18:747-53.
62. Spunberg JJ, Chang CH, Goldman M, Auricchio E, Bell JJ. Quality of long-term survival following irradiation for intracranial tumors in children under the age of two. Int J Radiat Oncol Biol Phys 1981; 7:727-36.
63. Duffner PK, Cohen ME, Thomas P. Late effects of treatment on the intelligence of children with posterior fossa tumors. Cancer 1983; 51:233-7.
64. Danoff BF, Cowchock FS, Marquette C, Mulgrew L, Kramer S. Assessment of the long-term effects of primary radiation therapy for brain tumors in children. Cancer 1982; 49:1580-6.
65. Grill J, Renaux VK, Bulteau C, et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys1999; 45:137-45.
66. Walter AW, Mulhern RK, Gajjar A, et al. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol 1999; 17:3720-8.
67. Radcliffe J, Bunin GR, Sutton LN, Goldwein JW, Phillips PC. Cognitive deficits in long-term survivors of childhood medulloblastoma and other noncortical tumors: Age-dependent effects of whole brain radiation. Int J Dev Neurosci 1994; 12:327-34.
68. Kiltie AE, Lashford LS, Gattamaneni HR. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Med Pediatr Oncol 1997; 28:348-54.
69. Baram TZ, Van Eys J, Dowell RE, Cangir A, Pack B, Bruner J. Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy - a preliminary report. Cancer 1987; 60:173-7.
70. Agerlin N, Gjerris F, Brincker H, etal. Childhood medulloblastoma in Denmark 1960-1984. A population-based retrospective study. Childs NervSyst 1999; 15:29-36.
71. Ater JL, van Eys J, Woo SY, Moore B, Copeland DR, Bruner J. MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children. J Neuro-Oncol 1997; 32:243-52.
72. Dupuis-Girod S, Hartmann O, Benhamou E, et al. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? J Neuro-Oncol 1996; 27:87-98.
73. Geyer JR, Zeltzer PM, Boyett JM, et al. Survival of infants with primitive neuroectodermal tumors and malignant ependymomas of the CNS treated with eight drugs in 1 day: A report from the Children's Cancer Group. J Clin Oncol 1994; 12:1607-16.
74. Kellie SJ. Chemotherapy of central nervous system tumours in infants. Childs Nerv Syst 1999; 15:592-612.
75. Kuhl J. Modern treatment strategies in medulloblastoma. Childs Nerv Syst 1998; 14:2-5.
76. Lashford LS, Campbell RH, Gattamaneni HR, Robinson K, Walker D, Bailey C. An intensive multiagent chemotherapy regimen for brain tumours occurring in very young children. Arch Dis Child 1996; 74:219-23.
77. Massimino M, Gandola L, Cefalo G, et al. Management of medulloblastoma and ependymoma in infants: A singleinstitution long-term retrospective report. Childs Nerv Syst 2000; 16:15-20.
78. Perilongo G, Massimino M, Sotti G, et al. Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group. Med Pediat Oncol 1997; 29:79-85.
79. White L, Kellie S, Gray E, et al. Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: Promising initial response to a VETOPEC-based regimen. A study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG). J Pediatr Hematol Oncol 1998; 2:125-30.
80. Kalifa C, Valteau D, Pizer B, Vassal G, Grill J, Hartmann O. High dose chemotherapy in childhood brain tumors. Childs Nerv Syst 1999; 15:498-505.
81. Dunkel IJ, Finlay JL. High dose chemotherapy with autologous stem cell rescue for patients with medulloblastoma. J Neuro-Oncol 1996; 29:69-74.
82. Bloom HJC, Wallace ENJ, Herk JM. The treatment and prognosis of medulloblastoma in children: A study of 82 verified cases. Am J Roentgenol 1969; 105:43-62.
83. Bamford FN, Jones PM, Pearson O, et al. Residual disabilities in children treated for intracranial space-occupying lesions. Cancer 1976; 37:1149-51.